Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersInfectious Disease Physician in Chapel Hill, NC
NPI: 1033321021Primary Practice Location
UNC HOSPITALS
101 Manning Dr, Chapel Hill, NC
Primary Employer
UNC Faculty Physicians
uncmedicalcenter.org
HQ Phone
Get M.D. Christopher's Phone Numberphone_androidMobile
Get M.D. Christopher's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 30 | 85 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 27 | 27 |
Authors: Lisa Hightow- Weidman
Journal: Clin Infect Dis
Authors: Greer Burkholder, Edward Cachay, Karla Perez-Goldberg, George Yendewa, Jimmy Ma, Mari Kitahata, Audrey Lloyd, Katerina Christopoulos
Journal: Open Forum Infect Dis
Publication Date: 2025-01-17
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
Authors: Rizwana Mohseni, James Krainson, Ruanne Barnabas, Rajesh Kunadharaju, Gary Herman, Gerard Acloque, Karen Vigil, Mary Marovich, Neil Stahl, Fernando Alvarado, Richard Perez Perez, Flonza Isa
Journal: N Engl J Med
Publication Date: 2021-10-06
Lead Sponsor: Emory University
Collaborators: National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Mississippi Medical Center, University of North Carolina, Chapel Hill
Intervention / Treatment: OTHER: ePrEP
Lead Sponsor: University of Minnesota
Collaborators: National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: REGN10933 + REGN10987
